{
    "Variants Include": [
      {
        "Gene": "PRKN",
        "variants": [
          {
            "HGVS": "NM_004562.3:c.125G>C",
            "cDNA Change": {
              "transcript": "NM_004562.3",
              "ref": "G",
              "alt": "C",
              "position": "125"
            },
            "Protein Change": {
              "ref": "R",
              "alt": "P",
              "position": "42"
            },
            "Description in input context": "R42P mutation in the Ubl domain associated with parkinsonism."
          },
          {
            "HGVS": "NM_004562.3:c.81G>T",
            "cDNA Change": {
              "transcript": "NM_004562.3",
              "ref": "G",
              "alt": "T",
              "position": "81"
            },
            "Protein Change": {
              "ref": "K",
              "alt": "N",
              "position": "27"
            },
            "Description in input context": "K27N mutation in the Ubl domain."
          },
          {
            "HGVS": "NM_004562.3:c.98G>A",
            "cDNA Change": {
              "transcript": "NM_004562.3",
              "ref": "G",
              "alt": "A",
              "position": "98"
            },
            "Protein Change": {
              "ref": "R",
              "alt": "Q",
              "position": "33"
            },
            "Description in input context": "R33Q mutation in the Ubl domain."
          },
          {
            "HGVS": "NM_004562.3:c.136G>C",
            "cDNA Change": {
              "transcript": "NM_004562.3",
              "ref": "G",
              "alt": "C",
              "position": "136"
            },
            "Protein Change": {
              "ref": "A",
              "alt": "P",
              "position": "46"
            },
            "Description in input context": "A46P mutation in the Ubl domain."
          },
          {
            "HGVS": "NM_004562.3:c.143A>G",
            "cDNA Change": {
              "transcript": "NM_004562.3",
              "ref": "A",
              "alt": "G",
              "position": "143"
            },
            "Protein Change": {
              "ref": "K",
              "alt": "R",
              "position": "48"
            },
            "Description in input context": "K48R mutation in the Ubl domain."
          }
        ]
      }
    ],
    "Described Disease": {
      "Disease": "Parkinson disease",
      "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
      {
        "Assay Method": "Autoubiquitination assays",
        "Material used": {
          "Material Source": "In vitro recombinant proteins",
          "Material Name": "Human recombinant E1, UBE2L3, Ubiquitin species, E3 species",
          "Description": "Reactions were conducted with human recombinant E1, UBE2L3, Ubiquitin species, and E3 species."
        },
        "Readout type": "Qualitative",
        "Readout description": [
          {
            "Variant": "NM_004562.3:c.125G>C",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "R42P mutation disrupts the autoinhibition of Parkin leading to increased autoubiquitination."
          },
          {
            "Variant": "NM_004562.3:c.81G>T",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "K27N mutation disrupts the autoinhibition of Parkin leading to increased autoubiquitination."
          },
          {
            "Variant": "NM_004562.3:c.98G>A",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "R33Q mutation disrupts the autoinhibition of Parkin leading to increased autoubiquitination."
          },
          {
            "Variant": "NM_004562.3:c.136G>C",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "A46P mutation disrupts the autoinhibition of Parkin leading to increased autoubiquitination."
          },
          {
            "Variant": "NM_004562.3:c.143A>G",
            "Conclusion": "Normal",
            "Molecular Effect": "No Effect",
            "Result Description": "K48R mutation does not affect the autoinhibition of Parkin."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "Yes",
          "Description": "N.D."
        },
        "Technical replicates": {
          "Technical replicates": "N.D.",
          "Description": "N.D."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "Wild-type Parkin serves as the positive control and does not show autoubiquitination activity."
        },
        "Basic negative control": {
          "Basic negative control": "N.D.",
          "Description": "N.D."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "N.D.",
          "Counts": "N.D."
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "N.D.",
          "Counts": "N.D."
        },
        "Statistical analysis method": {
          "Statistical analysis method": "N.D."
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "N.D.",
          "Source": "N.D."
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "N.D.",
          "Source": "N.D."
        },
        "Approved assay": {
          "Approved assay": "Yes"
        }
      },
      {
        "Assay Method": "Protein stability assays",
        "Material used": {
          "Material Source": "In vitro recombinant proteins",
          "Material Name": "Parkin species",
          "Description": "Proteolytic digests were carried out using subtilisin and thermal denaturation experiments were performed using DSF."
        },
        "Readout type": "Qualitative",
        "Readout description": [
          {
            "Variant": "NM_004562.3:c.125G>C",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "R42P mutation leads to decreased protein stability."
          },
          {
            "Variant": "NM_004562.3:c.81G>T",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "K27N mutation leads to decreased protein stability."
          },
          {
            "Variant": "NM_004562.3:c.98G>A",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "R33Q mutation leads to decreased protein stability."
          },
          {
            "Variant": "NM_004562.3:c.136G>C",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "A46P mutation leads to decreased protein stability."
          },
          {
            "Variant": "NM_004562.3:c.143A>G",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "K48R mutation leads to decreased protein stability."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "Yes",
          "Description": "N.D."
        },
        "Technical replicates": {
          "Technical replicates": "N.D.",
          "Description": "N.D."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "Wild-type Parkin serves as the positive control and shows normal protein stability."
        },
        "Basic negative control": {
          "Basic negative control": "N.D.",
          "Description": "N.D."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "N.D.",
          "Counts": "N.D."
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "N.D.",
          "Counts": "N.D."
        },
        "Statistical analysis method": {
          "Statistical analysis method": "N.D."
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "N.D.",
          "Source": "N.D."
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "N.D.",
          "Source": "N.D."
        },
        "Approved assay": {
          "Approved assay": "Yes"
        }
      },
      {
        "Assay Method": "NMR experiments",
        "Material used": {
          "Material Source": "In vitro recombinant proteins",
          "Material Name": "15N-labelled Ubl domain, Parkin species",
          "Description": "NMR experiments were performed using 15N-labelled Ubl domain and Parkin species."
        },
        "Readout type": "Qualitative",
        "Readout description": [
          {
            "Variant": "NM_004562.3:c.125G>C",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "R42P mutation affects the interaction between Ubl domain and Parkin."
          },
          {
            "Variant": "NM_004562.3:c.81G>T",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "K27N mutation affects the interaction between Ubl domain and Parkin."
          },
          {
            "Variant": "NM_004562.3:c.98G>A",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "R33Q mutation affects the interaction between Ubl domain and Parkin."
          },
          {
            "Variant": "NM_004562.3:c.136G>C",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "A46P mutation affects the interaction between Ubl domain and Parkin."
          },
          {
            "Variant": "NM_004562.3:c.143A>G",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "K48R mutation affects the interaction between Ubl domain and Parkin."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "Yes",
          "Description": "N.D."
        },
        "Technical replicates": {
          "Technical replicates": "N.D.",
          "Description": "N.D."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "Wild-type Parkin serves as the positive control and shows normal interaction between Ubl domain and Parkin."
        },
        "Basic negative control": {
          "Basic negative control": "N.D.",
          "Description": "N.D."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "N.D.",
          "Counts": "N.D."
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "N.D.",
          "Counts": "N.D."
        },
        "Statistical analysis method": {
          "Statistical analysis method": "N.D."
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "N.D.",
          "Source": "N.D."
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "N.D.",
          "Source": "N.D."
        },
        "Approved assay": {
          "Approved assay": "Yes"
        }
      },
      {
        "Assay Method": "Ubiquitin binding experiments",
        "Material used": {
          "Material Source": "In vitro recombinant proteins",
          "Material Name": "Parkin species, ubiquitin species",
          "Description": "Peptide arrays representing human full-length Parkin and recombinant UblD protein or ubiquitin were used for interaction detection."
        },
        "Readout type": "Qualitative",
        "Readout description": [
          {
            "Variant": "NM_004562.3:c.125G>C",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "R42P mutation affects the binding of Ubl domain to the ubiquitin-binding site in Parkin."
          },
          {
            "Variant": "NM_004562.3:c.81G>T",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "K27N mutation affects the binding of Ubl domain to the ubiquitin-binding site in Parkin."
          },
          {
            "Variant": "NM_004562.3:c.98G>A",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "R33Q mutation affects the binding of Ubl domain to the ubiquitin-binding site in Parkin."
          },
          {
            "Variant": "NM_004562.3:c.136G>C",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "A46P mutation affects the binding of Ubl domain to the ubiquitin-binding site in Parkin."
          },
          {
            "Variant": "NM_004562.3:c.143A>G",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "K48R mutation affects the binding of Ubl domain to the ubiquitin-binding site in Parkin."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "Yes",
          "Description": "N.D."
        },
        "Technical replicates": {
          "Technical replicates": "N.D.",
          "Description": "N.D."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "Wild-type Parkin serves as the positive control and shows normal binding of Ubl domain to the ubiquitin-binding site."
        },
        "Basic negative control": {
          "Basic negative control": "N.D.",
          "Description": "N.D."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "N.D.",
          "Counts": "N.D."
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "N.D.",
          "Counts": "N.D."
        },
        "Statistical analysis method": {
          "Statistical analysis method": "N.D."
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "N.D.",
          "Source": "N.D."
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "N.D.",
          "Source": "N.D."
        },
        "Approved assay": {
          "Approved assay": "Yes"
        }
      },
      {
        "Assay Method": "Effector protein binding experiments",
        "Material used": {
          "Material Source": "In vitro recombinant proteins",
          "Material Name": "Parkin species, EPS15 UIMs peptides, endophilin A1 SH3 domain",
          "Description": "Indicated quantities of Ubl species and E2s were incubated in Parkin autoubiquitination assays with custom peptides representing EPS15 UIMs or SH3 domains."
        },
        "Readout type": "Qualitative",
        "Readout description": [
          {
            "Variant": "NM_004562.3:c.125G>C",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "R42P mutation affects the ability of effector proteins to relieve the autoinhibition of Parkin."
          },
          {
            "Variant": "NM_004562.3:c.81G>T",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "K27N mutation affects the ability of effector proteins to relieve the autoinhibition of Parkin."
          },
          {
            "Variant": "NM_004562.3:c.98G>A",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "R33Q mutation affects the ability of effector proteins to relieve the autoinhibition of Parkin."
          },
          {
            "Variant": "NM_004562.3:c.136G>C",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "A46P mutation affects the ability of effector proteins to relieve the autoinhibition of Parkin."
          },
          {
            "Variant": "NM_004562.3:c.143A>G",
            "Conclusion": "Abnormal",
            "Molecular Effect": "gain-of-function",
            "Result Description": "K48R mutation affects the ability of effector proteins to relieve the autoinhibition of Parkin."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "Yes",
          "Description": "N.D."
        },
        "Technical replicates": {
          "Technical replicates": "N.D.",
          "Description": "N.D."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "Wild-type Parkin serves as the positive control and shows normal response to effector proteins."
        },
        "Basic negative control": {
          "Basic negative control": "N.D.",
          "Description": "N.D."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "N.D.",
          "Counts": "N.D."
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "N.D.",
          "Counts": "N.D."
        },
        "Statistical analysis method": {
          "Statistical analysis method": "N.D."
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "N.D.",
          "Source": "N.D."
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "N.D.",
          "Source": "N.D."
        },
        "Approved assay": {
          "Approved assay": "Yes"
        }
      }
    ]
  }